《腫瘤學(xué)年鑒》的成功建立在以下支柱之上:強(qiáng)大而不斷發(fā)展的社會(huì)(ESMO)的支持確保了卓越的標(biāo)準(zhǔn)。《腫瘤學(xué)年鑒》發(fā)表有關(guān)腫瘤學(xué)外科、放療、兒科腫瘤基礎(chǔ)研究和惡性腫瘤患者綜合管理的論文。每期包括教育臨床案例,原創(chuàng)文章,評(píng)論有爭(zhēng)議的新聞和信件。《腫瘤學(xué)年鑒》發(fā)表了來(lái)自世界各地專(zhuān)家的精選文章和社論。一般來(lái)說(shuō),文章在5周內(nèi)被評(píng)審,并在驗(yàn)收后的3個(gè)月內(nèi)發(fā)表。提供給《腫瘤學(xué)年鑒》的稿件退稿率在75%以上。
From Biology to Clinical practice : a modern approach of oncology. While giving space to review articles and paying more attention to biological aspects, the Bulletin du Cancer maintains a highly scientific clinical and therapeutic approach. The Bulletin du Cancer has now become one of the best scientific publications in the French language in the realm of cancerology. It is listed in the leading international databases. The Bulletin du Cancer is the journal of the Société Fran?aise du Cancer. The online version of Bulletin du Cancer is now available, offering seven years of archives that can be accessed by pay per view or by subscription.
SCI熱門(mén)推薦期刊 >
SCI常見(jiàn)問(wèn)題 >
職稱(chēng)論文常見(jiàn)問(wèn)題 >
EI常見(jiàn)問(wèn)題 >